Picard Medical is trading +11.63% at $5.95, with no new company-specific announcement identified for September 14.

  • The move continues the sharp September 11 advance.
  • Available coverage highlights prior litigation and investigation reports; broader markets are weaker pre-market, so the move does not clearly track overall risk sentiment.
  • The earlier CPI-related explanation applied to September 11, not a confirmed September 14 catalyst.